Intellia Therapeutics (NTLA) PT Lowered to $80 at Stifel
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.33 -2.84%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $80.00 (from $93.00) while maintaining a Buy rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- IGO Limited (IGO.AU) (IPGDF) PT Lowered to AUD6.90 at RBC Capital
- Greatland Resources Ltd (GGP:AU) PT Lowered to AUD13.50 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
